Nucleic Acid Immunity Meeting 2022

Keynotes

• Andrea Ablasser, Swiss Federal Institute of Technology (EPFL), Lausanne, Switzerland

• Zhijian 'James' Chen, University of Texas Southwestern Medical Center, Dallas, USA

• Raphaela Goldbach-Mansky, NIH National Institute of Allergy and Infectious Diseases, Bethesda, USA

 

Invited Speakers

• Dusan Bogunovic, Icahn School of Medicine at Mount Sinai, New York, USA

• Hana Cahova, Institute of Organic Chemistry and Biochemistry of the CAS, Prague, Czech Republic

• Roger Greenberg, University of Pennsylvania, Philadelphia, USA

• Veit Hornung, LMU Gene Center Munich, Germany

• Hiroki Kato, Institute of Cardiovascular Immunology, University Hospital Bonn, Germany

• Philip Kranzusch, Dana-Farber Cancer Institute, Harvard Medical School, USA

• Elke Krüger, University of Greifswald, Germany

• Min Ae Lee-Kirsch, University Hospital Carl Gustav Carus, TU Dresden, Germany

• Pingwei Li, Texas A&M University, USA

• John Maciejowski, Memorial Sloan Kettering Cancer Center, New York, USA

• Nicolas Manel, Institut Curie, Paris, France

• Kensuke Miyake, University of Tokyo, Japan

• Carina de Oliveira Mann, Institute of Virology, TU Munich, Germany

• Agnel Sfeir, Memorial Sloan Kettering Cancer Center, New York, USA

• Dan Stetson, University of Washington, Seattle, USA

• Stephen Tait, Cancer Research UK Beatson Institute, Glasgow, UK

• Phillip West, Texas A&M University College of Medicine, USA

• Nan Yan, University of Texas Southwestern Medical Center, Dallas, USA

 

Short Talk Speakers

• Stefan Bauer, Institute of Immunology, Marburg, Germany

• Olivia Majer, Max Planck Institute for Infection Biology, Berlin, Germany

• Liam Keegan, Central European Institute of Technology, Bro, Czech Republic

• Katherine Balka, Anatomy and Developmental Biology, Clayton, Australia

• Richard de Reuver, VIB Center for Inflammation Research, Gent, Belgium

• Alberto Ciccia, Columbia University Irving Medical Center, New York, USA

• Rayk Behrendt, Institute of Clinical Chemistry and Clinical Pharmacology, Bonn, Germany

• Andreas Pichlmair, Institute of Virology, Munich, Germany

• Axel Roers, Institute of Immunology, Heidelberg, Germany

• Eva Bartok, Institute of Experimental Hematology and Transfusion Medicine, Bonn, Germany

• Trine H. Mogensen, Department of Biomedicine, Aarhus, Denmark

• Manuele Rebsamen, Department of Biochemistry, Lausanne, Switzerland

• Thomas Zillinger, Institute of Clinical Chemistry and Clinical Pharmacology, Bonn. Germany